These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17010149

  • 1. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
    Koh SC, Singh K.
    J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
    [Abstract] [Full Text] [Related]

  • 2. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
    Rutanen E, Hurskainen R, Finne P, Nokelainen K.
    Fertil Steril; 2000 May; 73(5):1020-4. PubMed ID: 10785231
    [Abstract] [Full Text] [Related]

  • 3. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A, Hussain M, Rishworth JR, Rees MC.
    Cochrane Database Syst Rev; 2015 Apr 30; (4):CD002126. PubMed ID: 25924648
    [Abstract] [Full Text] [Related]

  • 4. Levonorgestrel-intrauterine system effects on hemostasis and menstrual blood loss in women seeking contraception.
    Koh SC, Singh K.
    J Obstet Gynaecol Res; 2010 Aug 30; 36(4):838-44. PubMed ID: 20666954
    [Abstract] [Full Text] [Related]

  • 5. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
    Prasad RN, Koh SC, Viegas OA, Ratnam SS.
    Clin Appl Thromb Hemost; 1999 Jan 30; 5(1):60-70. PubMed ID: 10725985
    [Abstract] [Full Text] [Related]

  • 6. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE, Cooke I, Rees M.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD002126. PubMed ID: 16235297
    [Abstract] [Full Text] [Related]

  • 7. The levonorgestrel intrauterine system in the management of menorrhagia.
    Barrington JW, Bowen-Simpkins P.
    Br J Obstet Gynaecol; 1997 May 19; 104(5):614-6. PubMed ID: 9166207
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U, Ebru A, Murat E, Levent Y.
    Int J Gynaecol Obstet; 2013 Nov 19; 123(2):146-9. PubMed ID: 24028852
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).
    Monteiro I, Bahamondes L, Diaz J, Perrotti M, Petta C.
    Contraception; 2002 May 19; 65(5):325-8. PubMed ID: 12057782
    [Abstract] [Full Text] [Related]

  • 10. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N, Soysal S, Sayan S, Yildizhan B, Karaman E, Cetin O, Tolunay HE, Yildizhan R.
    Gynecol Obstet Invest; 2018 May 19; 83(6):569-575. PubMed ID: 29223999
    [Abstract] [Full Text] [Related]

  • 11. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T, Toivonen J.
    Contraception; 1995 Nov 19; 52(5):269-76. PubMed ID: 8585882
    [Abstract] [Full Text] [Related]

  • 12. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
    Fong YF, Singh K.
    Contraception; 1999 Jul 19; 60(1):51-3. PubMed ID: 10549453
    [Abstract] [Full Text] [Related]

  • 13. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P, Paavonen J, Heikinheimo O.
    Contraception; 2007 Jan 19; 75(1):37-9. PubMed ID: 17161122
    [Abstract] [Full Text] [Related]

  • 14. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
    Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkilä A, Walker JJ, Cameron IT.
    Br J Obstet Gynaecol; 1998 Jun 19; 105(6):592-8. PubMed ID: 9647148
    [Abstract] [Full Text] [Related]

  • 15. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
    Kriplani A, Singh BM, Lal S, Agarwal N.
    Int J Gynaecol Obstet; 2007 Jun 19; 97(3):190-4. PubMed ID: 17382331
    [Abstract] [Full Text] [Related]

  • 16. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Contracept Reprod Health Care; 2001 Jun 19; 6(2):93-101. PubMed ID: 11518454
    [Abstract] [Full Text] [Related]

  • 17. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
    Lethaby AE, Cooke I, Rees M.
    Cochrane Database Syst Rev; 2000 Jun 19; (2):CD002126. PubMed ID: 10796865
    [Abstract] [Full Text] [Related]

  • 18. Treatment of menorrhagia with an LNG-IUS.
    Pakarinen P, Luukkainen T.
    Contraception; 2007 Jun 19; 75(6 Suppl):S118-22. PubMed ID: 17531601
    [Abstract] [Full Text] [Related]

  • 19. The Effect of Levonorgestrel on Fibrinolytic Factors in Human Endometrial Endothelial Cells.
    Pakrashi T, Taylor JE, Nelson A, Archer DF, Jacot T.
    Reprod Sci; 2016 Nov 19; 23(11):1536-1541. PubMed ID: 27130232
    [Abstract] [Full Text] [Related]

  • 20. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
    Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M.
    J Obstet Gynaecol Can; 2009 Apr 19; 31(4):340-347. PubMed ID: 19497153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.